CSL (OTCMKTS:CSLLY) Sees Large Volume Increase - Here's Why

Key Points

• CSL Limited experienced a significant increase in trading volume, with 116,586 shares traded, marking a 39% rise from the previous session's volume.
• The company's stock last traded at $69.56, down from a previous close of $70.42.
• CSL operates internationally across multiple segments including biopharmaceuticals and vaccines, specifically through CSL Behring, CSL Seqirus, and CSL Vifor.

CSL Limited Sponsored ADR (OTCMKTS:CSLLY - ) shares saw an uptick in trading volume on Monday . 116,586 shares traded hands during trading, an increase of 39% from the previous session's volume of 84,128 shares.The stock last traded at $69.56 and had previously closed at $70.42.

CSL Stock Performance

The stock has a 50-day moving average of $82.11 and a 200-day moving average of $80.23. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.85 and a current ratio of 1.86.

About CSL

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.